Biomarkers for tuberculosis disease activity, cure, and relapse

Lancet Infect Dis. 2010 Feb;10(2):69-70; author reply 70-1. doi: 10.1016/S1473-3099(09)70256-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Africa
  • Antitubercular Agents / therapeutic use
  • Asia
  • Biomarkers / analysis
  • Clinical Trials as Topic
  • Hong Kong
  • Humans
  • Multicenter Studies as Topic
  • Recurrence*
  • Tuberculosis, Pulmonary / diagnosis*
  • Tuberculosis, Pulmonary / drug therapy*
  • United Kingdom

Substances

  • Antitubercular Agents
  • Biomarkers